1. Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis

   • Min Kaiyin
   • Tong Lingling
   • Ji Bin

   Review 24 August 2023 Pages: 1 - 9

   

2. Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis

   • Nanna Jordt
   • Kasper Aalbæk Kjærgaard
   • Deirdre Cronin-Fenton

   Review Open access 01 September 2023 Pages: 11 - 22

   

3. Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study

   • Libo Yang
   • Heather Lin
   • Yun Wu

   Preclinical study 11 August 2023 Pages: 23 - 32

   

4. Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence

   • Bartosz Dołęga-Kozierowski
   • Piotr Kasprzak
   • Mariusz Ptak

   Preclinical study Open access 25 July 2023 Pages: 33 - 43

   

5. Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study

   • Lin Sui
   • Yuqi Yan
   • Dong Xu

   Preclinical study Open access 28 August 2023 Pages: 45 - 55

   

6. Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial

   • Cristiano de Pádua Souza
   • Ana Suellen Barroso Carneiro
   • Tomás Reinert

   Clinical Trial Open access 14 August 2023 Pages: 57 - 65

   

7. Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial

   • Léa L. Volmer
   • Dominik Dannehl
   • Andreas D. Hartkopf

   Clinical trial Open access 09 August 2023 Pages: 67 - 72

8. Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer

   • Matthew G. Davey
   • Ray Abbas
   • Michael J. Kerin

   Clinical trial Open access 04 August 2023 Pages: 73 - 81

9. CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis

   • Roya Behrouzi
   • Anne C. Armstrong
   • Sacha J. Howell

   Clinical trial Open access 16 August 2023 Pages: 83 - 95

   

10. High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors

    • Alv A. Dahl
    • Solveig K. Smedsland
    • Kristin V. Reinertsen

    Clinical trial Open access 01 August 2023 Pages: 97 - 104

11. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021

    • Judith A. Malmgren
    • Boya Guo
    • Henry G. Kaplan

    Epidemiology Open access 16 August 2023 Pages: 105 - 115

    

12. Increases in BMI contribute to worsening inflammatory biomarkers related to breast cancer risk in women: a longitudinal study

    • Yu Hao
    • Jinyu Xiao
    • Jiayuan Li

    Epidemiology 05 August 2023 Pages: 117 - 127

    

13. The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathology

    • Catherine S. Barker
    • Catherine W. Chung
    • Andrea M. Abbott

    Epidemiology 16 August 2023 Pages: 129 - 137

14. Effect of neighborhood deprivation index on breast cancer survival in the United States

    • Arya Mariam Roy
    • Anthony George
    • Shipra Gandhi

    Epidemiology Open access 05 August 2023 Pages: 139 - 153

    

15. Factors associated with insomnia symptoms over three years among premenopausal women with breast cancer

    • Chloe M. Beverly Hery
    • Sarah A. Janse
    • Michelle J. Naughton

    Epidemiology Open access 05 August 2023 Pages: 155 - 165

    

16. Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022

    • Niklas Gremke
    • Uwe Wagner
    • Karel Kostev

    Brief Communication Open access 31 July 2023 Pages: 167 - 172

    

17. Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients

    • Fengling Li
    • Hong Chen
    • Hong Bu

    Original Laboratory Investigation 01 August 2023 Pages: 173 - 183

    

18. Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram

    • Kimberlee A. Hashiba
    • Manisha Bahl

    Original Laboratory Investigation 30 July 2023 Pages: 185 - 190

19. Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

    • Lauren Lenz
    • Chris Neff
    • Kirsten M. Timms

    Original Laboratory Investigation Open access 17 August 2023 Pages: 191 - 201

    

20. Effects of neighborhood disadvantage on cortisol and interviewer-rated anxiety symptoms in breast cancer patients initiating treatment

    • Neha Goel
    • Alexandra E Hernandez
    • Michael H. Antoni

    Original Laboratory Investigation 10 August 2023 Pages: 203 - 211

    

21. Retraction Note: Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways

    • C. Buchanan
    • I. Stigliano
    • M. G. Peters

    Retraction Note 04 September 2023 Pages: 213 - 213